Open Access
Inflammation Meets Metabolism Roles: for the Receptor for Advanced Glycation End Products Axis in Cardiovascular Disease
Author(s) -
Laura M Senatus,
Michael MacLean,
Lakshmi Arivazhagan,
Lander Egaña-Gorroño,
Raquel LópezDíez,
Michaele B. Manigrasso,
Henry H. Ruiz,
Carolina Vásquez,
Robin A. Wilson,
Alexander Shekhtman,
Paul F. Gugger,
Ravichandran Ramasamy,
Ann Marie Schmidt
Publication year - 2021
Publication title -
immunometabolism
Language(s) - English
Resource type - Journals
ISSN - 2633-0407
DOI - 10.20900/immunometab20210024
Subject(s) - rage (emotion) , glycation , microbiology and biotechnology , immune system , inflammation , receptor , macrophage , lipid metabolism , signal transduction , biology , chemistry , immunology , biochemistry , neuroscience , in vitro
Fundamental modulation of energy metabolism in immune cells is increasingly being recognized for the ability to impart important changes in cellular properties. In homeostasis, cells of the innate immune system, such as monocytes, macrophages and dendritic cells (DCs), are enabled to respond rapidly to various forms of acute cellular and environmental stress, such as pathogens. In chronic stress milieus, these cells may undergo a re-programming, thereby triggering processes that may instigate tissue damage and failure of resolution. In settings of metabolic dysfunction, moieties such as excess sugars (glucose, fructose and sucrose) accumulate in the tissues and may form advanced glycation end products (AGEs), which are signaling ligands for the receptor for advanced glycation end products (RAGE). In addition, cellular accumulation of cholesterol species such as that occurring upon macrophage engulfment of dead/dying cells, presents these cells with a major challenge to metabolize/efflux excess cholesterol. RAGE contributes to reduced expression and activities of molecules mediating cholesterol efflux. This Review chronicles examples of the roles that sugars and cholesterol, via RAGE, play in immune cells in instigation of maladaptive cellular signaling and the mediation of chronic cellular stress. At this time, emerging roles for the ligand-RAGE axis in metabolism-mediated modulation of inflammatory signaling in immune cells are being unearthed and add to the growing body of factors underlying pathological immunometabolism.